ETF PROAI

Who holds CRSPCRISPR THERAPEUTICS AG

13 funds on our shelf carry CRISPR THERAPEUTICS AG — heaviest hand: GNOM at 2.73% of its book.

FundWeightFund assetsShares held
GNOMGlobal X Genomics & Biotechnology ETFINDEX2.73%$85M50,113
IDNAiShares Genomics Immunology and Healthcare ETFINDEX1.41%$282M78,584
XBIState Street SPDR S&P Biotech ETFINDEX1.02%$11B2,006,430
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.36%$102M6,830
IBBiShares Biotechnology ETFINDEX0.35%$10.7B700,407
VTWVVanguard Russell 2000 Value ETFINDEX0.30%$813M75,907
IWNiShares Russell 2000 Value ETFINDEX0.28%$14.2B759,792
RSSLGlobal X Russell 2000 ETFINDEX0.17%$1.5B43,061
IWMiShares Russell 2000 ETFINDEX0.17%$78B2,325,509
VTWOVanguard Russell 2000 ETFINDEX0.17%$9.9B535,930
ISCViShares Morningstar Small-Cap Value ETFINDEX0.16%$672M20,690
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFINDEX0.11%$352M6,860
XTiShares Exponential Technologies ETFINDEX0.03%$4.1B18,651

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.